Viewing Study NCT01968668


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2026-03-27 @ 2:37 AM
Study NCT ID: NCT01968668
Status: COMPLETED
Last Update Posted: 2021-07-16
First Post: 2013-10-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module